Journals / Annals of Medical Research / 2021 / Cilt: 28 - Sayı: 6

Seroprevalence of HBsAg, Anti-HCV and HIV in patientsundergoing ocular surgery

Pages
1139–1142
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Necessary precautions should be taken to preventcontamination to healthcare professionals and other patients during operation and medical care.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In this study, we aimed to detect the seroprevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), and humanimmunodeficiency virus (HIV) in patients undergoing ocular surgery.
📊
Key Findings & Data:Materials and Methods: HBsAg, anti-HCV, and HIVtestresults of patients who were admitted to the Department of Ophthalmologyof the Karabuk University Training and Research Hospital between March 2016 and April 2019 were retrospectively reviewed.HBsAg (Abbott Diagnostics, USA), anti-HCV(Abbott Diagnostics, USA) and HIV Ag/Ab Combo tests (Abbott Diagnostics, USA) wereassessed by chemiluminescence microparticleenzymeimmunoassaymethod byusingAbbottDiagnosticskits andARCHITECT i2000SR (Abbott Diagnostics, USA) immunoassayanalyzer.
💡
Conclusion & Impact:Necessary precautions should be taken to preventcontamination to healthcare professionals and other patients during operation and medical care.
🔬Design:Review & Systematic Survey
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: In this study, we aimed to detect the seroprevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), and humanimmunodeficiency virus (HIV) in patients undergoing ocular surgery. Materials and Methods: HBsAg, anti-HCV, and HIVtestresults of patients who were admitted to the Department of Ophthalmologyof the Karabuk University Training and Research Hospital between March 2016 and April 2019 were retrospectively reviewed.HBsAg (Abbott Diagnostics, USA), anti-HCV(Abbott Diagnostics, USA) and HIV Ag/Ab Combo tests (Abbott Diagnostics, USA) wereassessed by chemiluminescence microparticleenzymeimmunoassaymethod byusingAbbottDiagnosticskits andARCHITECT i2000SR (Abbott Diagnostics, USA) immunoassayanalyzer. Patients were divided into four groups according to age: 20–39, 40–59, 60–79,and 80 years old and above. Seropositive patients were evaluated in terms of the surgical method applied. Results: Of 1504 patients included in the study, 768 (51%) were men and 736 (49%) were women, and the mean age was 70 years.HBsAg positivity was 0.79% (12/1504) and anti-HCV positivity was 2.06% (31/1504). HIV Ag/Ab Combo was negative in all patients.There were no HBsAg and anti-HCV-positive patients in the 20–39 years age group, whereasone HBsAg (0.06%) and twoanti-HCV(0.13%) positivity in the 40–59 years age group and11 HBsAg (0.73%) and 23 anti-HCV (1.52%) positivity in the 60–79 years agegroup were detected. Although HBsAg was negative in all patients over 80 years old, anti-HCV was positive in 6(0.39%) patients.Further, eight of 12 HBsAg-positive patients underwent cataracts surgery and four lacrimal canal surgery, and 24 of 31 anti-HCVpositive patients underwent cataracts surgery, five lacrimal canal surgery, and two eyelid surgery. Conclusion: All patients should be tested for HBsAg, anti-HCV, and HIV preoperatively. Seropositive patients should be informedabout viral hepatitis and should be referred to the infectious diseases department. Necessary precautions should be taken to preventcontamination to healthcare professionals and other patients during operation and medical care.

🔖

Cite This Article

ÇAKMAKLIOĞULLARI, E. K., ÇAKMAKLIOĞULLARI, M. (2022). Seroprevalence of HBsAg, Anti-HCV and HIV in patientsundergoing ocular surgery. Annals of Medical Research, Cilt: 28 - Sayı: 6, 1139–1142. https://ajindex.com/articles/445906

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. World Health Organization. WHO Global Hepatitis Report; 2017. Availablefrom: http://www.who.int/ mediacentre/news/releases/2017/global hepatitis report/en/. [Lastaccessed on 2017 Oct 18]
  2. World Health Organization. Global Health Observatory (GHO) Data. Availablefrom: http://www.who.int/gho/ hiv/epidemic_status/cases_all/en/. [Last accessed on 2017 Oct 18]
  3. Ozkan H. HBV treatment in Turkey: The value of hepatitis B surface antigen quantification of chronic hepatitis B patients in thelong-termfollow-up-a single-centerstudy. Euroasian J Hepatogastroenterol 2017;7:82-83
  4. Celdir MG, Kara IA, Coşkuner SB, et al. Hepatitis C prevalence in Turkey: Estimation through metaanalysis. Eur J PubHeal 2014;24:168-9
  5. Collins CH, Kennedy DA. Microbiological hazards of occupational needles tick and ‘sharps’ injuries. J ApplBacteriol 1987;62:385-402
  6. Ching-YaoTsai, Chih-LinLin, Shiao-Cheng Lin, et al. Detection of Hepatitis B Virus in the Aqueous Humor of a Hepatitis B Virus Carrier. Opthalmologica 2009;223:93-5
  7. Sahu GK, McNearney T, Evans A, etal. Transient or occult HIV infections may occur more frequently than progressive infections: changing the paradigm about HIV persistence. Arch Virol Suppl 2005;19:131-45
  8. Raimondo G, Pollicino T, Cacciola I, etal. Occulthepatitis B virusinfection. J Hepatol 2007;46:160-70
  9. Tahir MA, Cheema A, Tareen S. Frequency of hepatitis-B and C in patients undergoing cataract surgery in a tertiary care centre. Pak J MedSci2015;31:895-8
  10. Ambastha A, Kusumesh R, Bhasker G. Why should viral markers be mandatory in ocular surgeries: A Hospital based retrospective study. J Clin Diagn Res 2016;10:9-11
  11. Alhassan MB, Unung P, Adejor G. HIV and HBsAg seropositivity amongs patients presenting for ocular surgery at a tertiary eye care hospital in Nigeria. Open Ophthalmol J 2013;7:18-9
  12. Baumert TF, Meredith L, Ni Y, et al. Entry of hepatitis B and C viruses -recen t progress and future impact. Curr Opin Virol 2014;4C:58-65
  13. Coppola N, De Pascalis S, Onorato L, et al. Hepatitis B virus and hepatitis C virus infection in health care workers. World J Hepatol 2016;8:273-81
  14. Shoaei P, Lofti N, Hassannejad R, et al. Seroprevalence of hepatitis C infection among laboratory health care workers in Isfahan, Iran. Int J PrevMed 2012;3:146-9
  15. Kose S, Odemiş I, Celik D, et al. Hepatitis A, B, C and HIV seroprevalence among Syrian refugee children admitted to outpatient clinics. Infez Med 2017;25:339- 43
  16. Inci H, As